Find an Expert
Search
Menu
Help
Report an issue
The Role for Intra-operative Botulinum Toxin Type A in Reducing Complications in Reconstructive Head and Neck Cancer Patients
| Funding period: 2020 - 2022
Active
Researchers
Anand Ramakrishnan